These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 947175)

  • 21. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of bromocriptine on the pressor responses to afferent nervous stimulation.
    Montastruc JL; Gaillard-Plaza G; Montastruc P
    J Pharmacol; 1984; 15(2):169-76. PubMed ID: 6738075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action of tetramethylpyrazine on cardiovascular system in the anesthetized dog (preliminary study) (author's transl)].
    Wang BZ; Yang MG; Pang L; Yu ZJ
    Yao Xue Xue Bao; 1979; 14(10):624-7. PubMed ID: 539430
    [No Abstract]   [Full Text] [Related]  

  • 25. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
    Osborne MW; Wenger JJ; Willems W
    J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the mechanism of action of 1-(2-methyl-3-hydroxy-5-hydroxy-methyl-4-pyridyl)-6,7-dihydroxy-1,2,3, 4- tetrahydroisoquinoline (PTIQ) on blood pressure in the anesthetized dog.
    Siu PM; Vick JA
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):421-33. PubMed ID: 2781139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function.
    Kövér G; Fekete M; Tost H; Szemerédi K
    Acta Physiol Hung; 1988; 72(3-4):321-33. PubMed ID: 3250211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effect of theophylline on the cardiac response to isoproterenol.
    Cusack BJ; Nielson CP; Morgan ME; Vestal RE
    Clin Pharmacol Ther; 1987 Mar; 41(3):289-96. PubMed ID: 3816017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action.
    Aman MG; Werry JS
    Psychopharmacologia; 1975 Aug; 43(2):163-8. PubMed ID: 1103207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of a new macrolide, midecamycin on theophylline pharmacokinetics (author's transl)].
    Lavarenne J; Paire M; Talon O
    Therapie; 1981; 36(4):451-6. PubMed ID: 7292428
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxicological properties of biperiden in overdose in the dog.
    Sangster B; van Heijst AN; Zimmerman AN
    Vet Hum Toxicol; 1979; 21 Suppl():97-9. PubMed ID: 506001
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proceedings: 123. Studies on a model of non-shivering thermogenesis in vivo (author's transl)].
    Kurahashi M
    Nihon Seirigaku Zasshi; 1973; 35(8):433-4. PubMed ID: 4799319
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical examination of a new water-soluble theophylline body].
    HILLER E
    Med Klin; 1954 Dec; 49(50):1990-2. PubMed ID: 13235218
    [No Abstract]   [Full Text] [Related]  

  • 36. [Psychopharmacology of haloperidol].
    Janssen PA
    Acta Psiquiatr Psicol Am Lat; 1979 Dec; 25(4):307-16. PubMed ID: 546060
    [No Abstract]   [Full Text] [Related]  

  • 37. A hypotensive phospholipid from dog peritoneal dialysate.
    Tsukatani H; Yamada S; Tokumura A; Takauchi K; Itami T
    J Pharm Pharmacol; 1979 Aug; 31(8):569-71. PubMed ID: 40007
    [No Abstract]   [Full Text] [Related]  

  • 38. [Photo-stability of theophylline in aqueous aliphatic amine solutions under oxygen (author's transl)].
    Ishiguro Y; Sawada M; Kusube K; Kawabe K
    Yakugaku Zasshi; 1981 Dec; 101(12):1159-63. PubMed ID: 7338806
    [No Abstract]   [Full Text] [Related]  

  • 39. Concerning drug interactions with theophylline.
    Zucchero FJ; Hogan MJ
    J Emerg Med; 1990; 8(4):500-3. PubMed ID: 2212576
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of bilateral nephrectomy upon the metabolism of theophylline in the dog.
    WAXLER SH; SCHACK JA
    Stanford Med Bull; 1951 May; 9(2):94-5. PubMed ID: 14855181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.